Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that will make the kidney disease drug developer the first U.S. biotech ...
Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...
We expect Dynatrace to generate strong free cash flow margins as it increases its operating leverage while driving its top line forward. We see this trend as typical in the high-growth software space ...
The lawyer behind a series of high-profile legal challenges to DEI practices is suing Bally’s and the city of Chicago over a $250 million IPO the suit says is unlawfully open only to people of color ...
Robinhood CEO Vlad Tenev’s proposal for tokenized equity sales offers a sensible third way between exempt securities and public offerings, deepening the capital available to businesses of all sizes, ...
Here is a glimpse of local programs and events for children and teens in Hancock County. To submit an event for a future listing, email [email protected].